How is the Context Therapeutics Inc today?

The Context Therapeutics Inc today is trading in the green, up by 1.54% at 0.66.

How has Context Therapeutics Inc performed historically?

The Context Therapeutics Inc is currently trading up 1.54% on an intraday basis in the past week the index rose 15.79%. The index has been down -10.81% in the past quarter and fell -67.16% in the past year. You can view this in the overview section.

What is Context Therapeutics Inc Annual Net Profit?

Context Therapeutics Inc Annual Net Profit fell 11.52% in the last year to $26.73 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Context Therapeutics Inc Price to Earning Ratio?

Context Therapeutics Inc Price to Earning Ratio is -2.14, which is negative.

What is Context Therapeutics Inc Stock Price?

Context Therapeutics Inc Stock Price fell 67.16% and underperformed its sector by 102.03% in the past year.

What is Context Therapeutics Inc Quarterly Net profit?

Context Therapeutics Inc Quarterly Net profit fell 24.8% YoY to $4.58 M. Its sector's average net profit growth YoY for the quarter was -235.94%.

What is Context Therapeutics Inc Debt to Equity Ratio?

Context Therapeutics Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Context Therapeutics Inc Return on Equity(ROE)?

Context Therapeutics Inc Return on Equity(ROE) for the last financial year was -49.89%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Context Therapeutics Inc Mutual Fund Holding?

Context Therapeutics Inc Mutual Fund Holding increased by 0.12% in the last quarter to 13.65.

What is Context Therapeutics Inc Institutional Holding?

Context Therapeutics Inc Institutional Holding remained the same in the last quarter at 89.2%.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
CONTEXT THERAPEUTICS INC

Context Therapeutics Inc XNAS: CNTX

Context Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Context Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Context Therapeutics Inc
Rating: 1.12283325
Author: Trendlyne DVM scores

about

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...

0.66 0.01 (1.54%)

76.00% Fall from 52W High

87,365

XNAS Volume

XNAS 27 Jun, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

13.8 / 100

Technically Bearish

31.1 / 100

No estimates available

Context Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Context Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...

76.00% Fall from 52W High

SWOT Analysis

Context Therapeutics Inc Live Price Chart

Context Therapeutics Inc FAQ

How is Context Therapeutics Inc today?

Context Therapeutics Inc today is trading in the green, and is up by 1.54% at 0.66.

How has Context Therapeutics Inc performed historically?

Context Therapeutics Inc is currently trading up 1.54% on an intraday basis. In the past week the stock rose 15.79%. stock has been down -10.81% in the past quarter and fell -67.16% in the past year. You can view this in the overview section.